The persistence of a MRD in most CML patients, sometimes undetectable by standard techniques, is due to a pool of TKI-persistent and BCR–ABL1 kinase–independent LSCs. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.